Global Platelet Aggregation Devices Market Size study, by Product (Systems, Reagents, Consumables and Accessories), by Application (Research Applications, Clinical Applications, Cardiovascular Applications, Orthopedic Applications) and Regional Forecasts 2022-2028
Global Platelet Aggregation Devices Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Platelet Aggregation is substances such as collagen, ristocetin, arachidonic acid, adenosine 5′-diphosphate (ADP), epinephrine, and thrombin can stimulate platelets and hence induce aggregation. Response to these aggregating agents (known as agonists) provides a diagnostic pattern for different disorders of platelet function. Also, the Platelet Aggregation Devices are used for treating injuries and illnesses that need immediate care. The technological advancements in platelet, increasing geriatric population has led to the adoption of Platelet Aggregation Devices across the forecast period. For Instance: According to the UN, world’s population is expected to increase by 2 billion persons in the next 30 years, from 7.7 billion currently to 9.7 billion in 2050 and could peak at nearly 11 billion around 2100. Also, with the growing number of surgical procedures, the adoption & demand for Platelet Aggregation Devices is likely to increase the market growth during the forecast period. However, procedural limitations impede the growth of the market over the forecast period of 2022-2028.
The key regions considered for the Global Platelet Aggregation Devices Market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the significant region across the world in terms of market share owing to the attractive destination for companies engaged in the development, manufacture, and distribution of platelet aggregation products. Whereas, Asia-Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2022-2028. Factors such as rising disposable income, growing number of surgical procedures, rising awareness among healthcare professionals and improving healthcare infrastructure would create lucrative growth prospects for the Platelet Aggregation Devices Market across Asia-Pacific region.
Major market players included in this report are:
Aggredyne, Inc.
F. Hoffmann La-Roche Ltd.
Haemonetics Corporation
Sysmex Corporation
Siemens AG
Accriva Diagnostics
Helena Laboratories Corporation
Bio/Data Corporation
Tem Group
Sentinel CH. S.p.A.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Systems
Reagents
Consumables and Accessories
By Application:
Research Applications
Clinical Applications
Cardiovascular Applications
Orthopedic Applications
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Platelet Aggregation Devices Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Companies Mentioned
Aggredyne, Inc.
F. Hoffmann La-Roche Ltd.
Haemonetics Corporation
Sysmex Corporation
Siemens AG
Accriva Diagnostics
Helena Laboratories Corporation
Bio/Data Corporation
Tem Group
Sentinel CH. S.p.A.
Please note: The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook